Topically Applied Therapies for the Treatment of Skin Disease: Past, Present, and Future

Marc Brown, Adrian Williams, Robert P. Chilcott, Brendan Brady, Jon Lenn, Charles Evans, Lynn Allen, William J. McAuley, Mubinah Beebeejaun, Jasmin Haslinger, Claire Beuttel, Raquel Vieira, Florencia Guidali, Margarida Miranda

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

The purpose of this review is to summarize essential biological, pharmaceutical, and clinical aspects in the field of topically applied medicines that may help scientists when trying to develop new topical medicines. After a brief history of topical drug delivery, a review of the structure and function of the skin and routes of drug absorption and their limitations is provided. The most prevalent diseases and current topical treatment approaches are then detailed, the organization of which reflects the key disease categories of autoimmune and inflammatory diseases, microbial infections, skin cancers, and genetic skin diseases. The complexity of topical product development through to large-scale manufacturing along with recommended risk mitigation approaches are then highlighted. As such topical treatments are applied externally, patient preferences along with the challenges they invoke are then described, and finally the future of this field of drug delivery is discussed, with an emphasis on areas that are more likely to yield significant improvements over the topical medicines in current use or would expand the range of medicines and diseases treatable by this route of administration.

Original languageEnglish
Pages (from-to)689-790
Number of pages102
JournalPharmacological Reviews
Volume76
Issue number5
DOIs
Publication statusPublished - 1 Sept 2024

Fingerprint

Dive into the research topics of 'Topically Applied Therapies for the Treatment of Skin Disease: Past, Present, and Future'. Together they form a unique fingerprint.

Cite this